# Biodexa Pharmaceuticals Plc: Form 6-K, filed Jun 14, 2023

- Company: [Biodexa Pharmaceuticals Plc](/companies/bdrx.md) (CIK 1643918)
- Form: 6-K
- Filed: 2023-06-14
- Accepted by EDGAR: Jun 14, 2023, 08:35 ET
- Period: 2023-06-14
- Accession: 0001171843-23-003917
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1643918/000117184323003917/f6k_061423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1643918/000117184323003917/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1643918/000117184323003917/f6k_061423.htm

Filed Jun 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-003917. Last ingested by Listed: Nov 9, 2026, 17:57 ET. No prices; not investment advice.
